Filing Flows › Comparisons › PMHS vs CTXR
Polomar Health Services vs Citius Pharmaceuticals: PMHS and CTXR compared
Polomar Health Services is the larger company: $1.5M of revenue in its latest quarter (Q2 2026) against $1.5M for Citius Pharmaceuticals (Q3 FY26). Polomar Health Services is more profitable, with an operating margin of 14.3% against -785.4%.
Where the money goes: PMHS and CTXR
Polomar Health Services (PMHS) · Q2 2026
Polomar Health Services, Q2 2026: revenue $1.5M (279× year over year), operating margin 14.3%, net earnings $200K, operating cash flow $121K. The chart follows the revenue to costs, profit and cash.
Citius Pharmaceuticals (CTXR) · Q3 FY26
Citius Pharmaceuticals, Q3 FY26: revenue $1.5M, operating margin -785.4%, net loss $11.9M, operating cash flow −$8.7M. The chart follows the revenue to costs, profit and cash.
| Polomar Health Services (PMHS) | Citius Pharmaceuticals (CTXR) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q3 FY26 |
| Revenue | $1.5M | $1.5M |
| Revenue growth, Y/Y | 279× | — |
| Gross margin | 61.2% | — |
| Operating margin | 14.3% | -785.4% |
| Net earnings | $200K | −$11.9M |
| Net margin | 13.1% | -797.9% |
| Operating cash flow | $121K | −$8.7M |
Questions
Which is bigger, Polomar Health Services or Citius Pharmaceuticals?
Polomar Health Services is the larger company: $1.5M of revenue in its latest quarter (Q2 2026) against $1.5M for Citius Pharmaceuticals (Q3 FY26).
Is Polomar Health Services or Citius Pharmaceuticals growing faster?
Polomar Health Services is more profitable, with an operating margin of 14.3% against -785.4%.
More: Polomar Health Services earnings · how Polomar Health Services makes money · Citius Pharmaceuticals earnings · how Citius Pharmaceuticals makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 14, 2026; 10-Q filed Aug 14, 2026). Fiscal quarters can end on different dates. Not investment advice.